Events

Retiro De Equipo (Recall) de BioSensors_BioMatrix NeoFlex Drug Eluting Coronary Stent System

Según New Zealand Medicines and Medical Devices Safety Authority, este evento ( retiro de equipo (recall) ) involucró a un dispositivo médico en New Zealand que fue producido por Biosensors Europe SA.

¿Qué es esto?

Una corrección al equipo o acción de retiro tomada por el fabricante para abordar un problema con un dispositivo médico. Los retiros (recalls) ocurren cuando un dispositivo médico está defectuoso, cuando puede poner en riesgo la salud, o cuando simultáneamente está defectuoso y puede poner en riesgo la salud.

Más información acerca de la data acá
  • Tipo de evento
    Recall
  • ID del evento
    19857
  • Fecha de inicio del evento
    2016-03-07
  • País del evento
    New Zealand
  • Fuente del evento
    NZMMDSA
  • URL de la fuente del evento
    https://medsafe.govt.nz/hot/Recalls/RecallSearch.asp
  • Notas / Alertas
    Data from New Zealand is current through July 2018. All of the data comes from the New Zealand Medicines and Medical Devices Safety Authority, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and New Zealand.
  • Notas adicionales en la data
    Recalling Organisation: InterMed Medical Ltd, 71 Apollo Drive, Albany, AUCKLAND 1311
  • Causa
    Manufacturer discovered during routine lot release testing that several production lots did not meet the balloon rated burst performance specifications. after full investigation, manufacturer concluded that the compromised balloon performance was caused by certain characteristics in the manufacturing process. biosensors positively identified production lots manufactured between october to december 2015 that could have been similarly affected., the compromised balloon performance may potentially lead to delay in inflation or deflation of the balloon; or balloon burst when the balloon is inflated above the nominal pressure. this could result in procedural complications and lead to serious deterioration in the patient's state of health during pci., patients who have already been implanted with an affected device are not impacted by this field safety corrective action. no field complaint or patient injury has been reported associated with the compromised balloon performance.
  • Acción
    Product to be returned to supplier

Device

BioSensors_BioMatrix NeoFlex Drug Eluting Coronary Stent System
  • Modelo / Serial
    Model: BMXP-3511, BMXP-3518, BMXP-4018, BMXP-4024, Affected: Batches: W15100548 W15100236 W15100237 W15100238 W15110086 W15120234
  • Manufacturer
    Biosensors Europe SA

Manufacturer

Biosensors Europe SA